THE ROLE OF DYSHORMONAL DISORDERS OF LEPTIN AND GHRELIN IN THE DEVELOPMENT OF DYSLIPIDEMIA AND METABOLIC SYNDROME
Keywords:
CKM; dyshormonal disorders, leptin, ghrelin, сardiovascular metabolic syndrome, metabolic syndrome, obesity; American Heart Association (AHA), hepatoprotector.Abstract
Epidemiologic data from observational studies and clinical trials provide substantial evidence of significant overlap between metabolic and cardiovascular diseases. Recognizing this complex relationship, the American Heart Association (AHA) recently introduced the concept of a combined disease known as cardiovascular and metabolic syndrome (CKM), emphasizing the close association and interaction between these areas of health. The purpose of this study is to provide a comprehensive and critical analysis of the current state of play regarding the newly defined CKM syndrome. This includes an examination of the epidemiologic and experimental data establishing links between cardio-metabolic diseases, an exploration of the underlying pathophysiological mechanisms and a comprehensive review of existing treatments.
References
1.Interconnection between cardiovascular and metabolic disorders: a narrative review with a focus on Japan. T. Kadowaki et al 2023...
2. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2023 update: a report from the American heart association Circulation 2023 Heart Disease and Stroke Statistics Update Fact Sheet At-a-Glance. AHA. Accessed on Oct 11, 2023....
3.The cardio-metabolic connection: a review of the evidence Cardiovasc Diabetol (2023) C.W. Tsao et al.
4.American heart association. A synopsis of the evidence for the science and clinical management of cardiovascular-Metabolic (CM) syndrome: a scientific statement from the American heart association Circulation (2023) V.L. Roger et al.
5.Management of cardiorenal metabolic syndrome: a phytotherapeutic perspective Diabetes Res (2023) K.C. Ferdinand et al.
6.Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations Cardiorenal Med (2024)S.V. Arnold et al.
7.American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics–2012 update: a report from the American heart association Circulation (2024) M.K. Song et al.
8.American heart association. Cardiovascular-metabolic health: a presidential advisory from the American heart association Circulation (2023) C.E. Ndumele et al.
9.Burden of cardio-metabolic conditions in adults within the diabetes collaborative registry Diabetes Obes Metab (2018) J.W. Ostrominski et al.
10.Cardio-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction JACC Heart Fail (2023) M.J. O'Brien et al.
11.Mechanisms of an oxidative stress in Cardiovascular-metabolic syndrome: JACC state-of-the-art review
J Am Coll Cardiol (2020) T.A. Zelniker et al.
12.The role of exercise and physical activity in weight loss and maintenance
Prog Cardiovasc Dis (2024) D.L. Swift et al.
13.Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trialsLancet (2023) D.P. Vivekananthan et al.
14.Жировой гепатоз- как один из актуальных вопросов гепатологии Л.Туеега, Б.С.Энааш, Л.П.Мгнатева 2023 13-15стр.
